CDT Equity files Sarborg acquisition financials: FY25 revenue $4.6M, net loss $508K, going concern risk

CDT Equity Inc.

Sarborg FY2025 revenue $4.626M vs $98K in 2024 (inception Oct 28, 2024); net loss $508K vs $282K.
Sarborg had $10K cash and $790K accumulated deficit at Dec 31, 2025; founder guaranty covers cash shortfalls for 18 months.
Sarborg is an agentic AI platform decoding biological, chemical, industrial signatures for drug repurposing and disease insights.
CDT filed unaudited pro forma condensed consolidated statements giving effect to the Sarborg investment (Exhibit 99.3).
Unaudited interim Sarborg financials for six months ended June 30, 2026 filed as Exhibit 99.2.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.